相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pathogenesis and Treatment of Pancreatic Cancer Related Pain
Ines Lohse et al.
ANTICANCER RESEARCH (2020)
Co-targeting EGFR and mTOR with gefitinib and everolimus in triple-negative breast cancer cells
Abderrahim El Guerrab et al.
SCIENTIFIC REPORTS (2020)
Identification of the Novel Target Genes for Osteosarcoma Therapy Based on Comprehensive Bioinformatic Analysis
Xi Zhou et al.
DNA AND CELL BIOLOGY (2020)
miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer
Shizong Li et al.
HUMAN CELL (2020)
GLI1 overexpression promotes gastric cancer cell proliferation and migration and induces drug resistance by combining with the AKT-mTOR pathway
Yizhou Yao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Everolimus in combination with Imatinib overcomes resistance in Chronic myeloid leukaemia
Raquel Alves et al.
MEDICAL ONCOLOGY (2019)
Therapeutic Drug Monitoring of Everolimus in Oncology: Evidences and Perspectives
Sabrina Falkowski et al.
THERAPEUTIC DRUG MONITORING (2019)
DEPTOR inhibits cell proliferation and confers sensitivity to dopamine agonist in pituitary adenoma
Hong Yao et al.
CANCER LETTERS (2019)
mTOR: Role in cancer, metastasis and drug resistance
Avaniyapuram Kannan Murugan
SEMINARS IN CANCER BIOLOGY (2019)
Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells
Chieh-Yu Lan et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Bromodomain-containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2-antagonist/killer protein
Jinqi Ma et al.
ONCOLOGY REPORTS (2019)
Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer
Dharmalingam Subramaniam et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Genistein reduces the activation of AKT and EGFR, and the production of IL6 in cholangiocarcinoma cells involving estrogen and estrogen receptors
Pariyada Tanjak et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Phase I trial of the mTOR inhibitor everolimus in combination with multi-agent chemotherapy in relapsed childhood acute lymphoblastic leukemia
Andrew E. Place et al.
PEDIATRIC BLOOD & CANCER (2018)
Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G0/G1cell cycle arrest and regulation of STAT3 signalling pathway
Bi Yi-liang et al.
PHYTOMEDICINE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Everolimus Inhibits Growth of Gemcitabine-Resistant Pancreatic Cancer Cells via Induction of Caspase-Dependent Apoptosis and G2/M Arrest
Tao Peng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
GAS6-expressing and self-sustaining cancer cells in 3D spheroids activate the PDK-RSK-mTOR pathway for survival and drug resistance
Christine Baumann et al.
MOLECULAR ONCOLOGY (2017)
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting
Daniele Generali et al.
ONCOLOGIST (2017)
Quantitative proteomics profiling reveals activation of mTOR pathway in trastuzumab resistance
Wenhu Liu et al.
ONCOTARGET (2017)
Activation of the mTOR Pathway by Oxaliplatin in the Treatment of Colorectal Cancer Liver Metastasis
Min Lu et al.
PLOS ONE (2017)
Genistein: Its role in metabolic diseases and cancer
Vidya Mukund et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Cristoforo Grasso et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US
Nanxin Li et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Reciprocal Negative Regulation between EGFR and DEPTOR Plays an Important Role in the Progression of Lung Adenocarcinoma
Xuefeng Zhou et al.
MOLECULAR CANCER RESEARCH (2016)
A phase I dose escalation trial of AXP107-11, a novel multi-component crystalline form of genistein, in combination with gemcitabine in chemotherapy-naive patients with unresectable pancreatic cancer
Johannes-Matthias Lohr et al.
PANCREATOLOGY (2016)
Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer
S. Kordes et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Genistein and Cancer: Current Status, Challenges, and Future Directions
Carmela Spagnuolo et al.
ADVANCES IN NUTRITION (2015)
Genistein Inhibits Cell Growth and Invasion Through Regulation of miR-27a in Pancreatic Cancer Cells
Jun Xia et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Synthetic Genistein Glycosides Inhibiting EGFR Phosphorylation Enhance the Effect of Radiation in HCT 116 Colon Cancer Cells
Aleksandra Gruca et al.
MOLECULES (2014)
Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds
Yu Huang et al.
ONCOLOGY REPORTS (2013)
分享论文
